Transcription Factor Runx2 Promotes Aortic Fibrosis and Stiffness in Type 2 Diabetes Mellitus.

RATIONALE Accelerated arterial stiffening is a major complication of diabetes mellitus with no specific therapy available to date. OBJECTIVE The present study investigates the role of the osteogenic transcription factor runt-related transcription factor 2 (Runx2) as a potential mediator and therapeutic target of aortic fibrosis and aortic stiffening in diabetes mellitus. METHODS AND RESULTS Using a murine model of type 2 diabetes mellitus (db/db mice), we identify progressive structural aortic stiffening that precedes the onset of arterial hypertension. At the same time, Runx2 is aberrantly upregulated in the medial layer of db/db aortae, as well as in thoracic aortic samples from patients with type 2 diabetes mellitus. Vascular smooth muscle cell-specific overexpression of Runx2 in transgenic mice increases expression of its target genes, Col1a1 and Col1a2, leading to medial fibrosis and aortic stiffening. Interestingly, increased Runx2 expression per se is not sufficient to induce aortic calcification. Using in vivo and in vitro approaches, we further demonstrate that expression of Runx2 in diabetes mellitus is regulated via a redox-sensitive pathway that involves a direct interaction of NF-κB with the Runx2 promoter. CONCLUSIONS In conclusion, this study highlights Runx2 as a previously unrecognized inducer of vascular fibrosis in the setting of diabetes mellitus, promoting arterial stiffness irrespective of calcification.

[1]  M. Mayr,et al.  Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. , 2015, Circulation research.

[2]  C. St. Hilaire,et al.  Medial vascular calcification revisited: review and perspectives. , 2014, European heart journal.

[3]  Yong Sun,et al.  Activation of AKT by O-Linked N-Acetylglucosamine Induces Vascular Calcification in Diabetes Mellitus , 2014, Circulation research.

[4]  P. Tsao,et al.  Hemodynamic regulation of reactive oxygen species: implications for vascular diseases. , 2014, Antioxidants & redox signaling.

[5]  Yawei Xu,et al.  Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway , 2014, Diabetes & vascular disease research.

[6]  Bradley S. Fleenor,et al.  Superoxide signaling in perivascular adipose tissue promotes age-related artery stiffness , 2014, Aging cell.

[7]  Cynthia A. Reinhart-King,et al.  Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity , 2013, Hypertension.

[8]  M. Daemen,et al.  Biomechanical factors as triggers of vascular growth. , 2013, Cardiovascular research.

[9]  Elena Aikawa,et al.  Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.

[10]  Yong Sun,et al.  Smooth Muscle Cell–Specific Runx2 Deficiency Inhibits Vascular Calcification , 2012, Circulation research.

[11]  Mazyar Amin,et al.  Mechanical testing of mouse carotid arteries: from newborn to adult. , 2012, Journal of visualized experiments : JoVE.

[12]  Jessica E Wagenseil,et al.  Elastin in Large Artery Stiffness and Hypertension , 2012, Journal of Cardiovascular Translational Research.

[13]  E. Lakatta,et al.  Role of Inflammation in the Pathogenesis of Arterial Stiffness , 2012, Yonsei medical journal.

[14]  L. Game,et al.  Activating Transcription Factor 1 Directs Mhem Atheroprotective Macrophages Through Coordinated Iron Handling and Foam Cell Protection , 2012, Circulation research.

[15]  Myung-Shik Lee,et al.  Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells , 2011, Experimental & Molecular Medicine.

[16]  Charles A. Taylor,et al.  The Use of Immunofluorescent Array Tomography to Study the Three-Dimensional Microstructure of Murine Blood Vessels , 2011 .

[17]  Alban Redheuil,et al.  Aortic stiffness: current understanding and future directions. , 2011, Journal of the American College of Cardiology.

[18]  Yin Tintut,et al.  Regulatory mechanisms in vascular calcification , 2010, Nature Reviews Cardiology.

[19]  A. Xu,et al.  Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. , 2010, Antioxidants & redox signaling.

[20]  R. Mecham,et al.  Vascular extracellular matrix and arterial mechanics. , 2009, Physiological reviews.

[21]  Yun Zhang,et al.  Impaired Elastic Properties of the Aorta in Fat-Fed, Streptozotocin-Treated Rats , 2009, Cardiology.

[22]  C. Wilcox,et al.  Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides , 2008, Pharmacological Reviews.

[23]  J. Kappes,et al.  Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling* , 2008, Journal of Biological Chemistry.

[24]  M. Cooper,et al.  Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail , 2008, Diabetes.

[25]  C. D. A. Stehouwer,et al.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease , 2008, Diabetologia.

[26]  M. O'Rourke,et al.  Mechanical factors in arterial aging: a clinical perspective. , 2007, Journal of the American College of Cardiology.

[27]  D. Harrison,et al.  Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. , 2007, American journal of physiology. Heart and circulatory physiology.

[28]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[29]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[30]  S. Kihara,et al.  Adiponectin Inhibits Endothelial Synthesis of Interleukin-8 , 2005, Circulation research.

[31]  C. Vlachopoulos,et al.  Acute Systemic Inflammation Increases Arterial Stiffness and Decreases Wave Reflections in Healthy Individuals , 2005, Circulation.

[32]  J. Schwartz,et al.  Arterial Stiffness in Chronic Inflammatory Diseases , 2005, Hypertension.

[33]  Dean Y. Li,et al.  Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. , 2005, American journal of physiology. Heart and circulatory physiology.

[34]  M. Engelse,et al.  Expression of Runx2/Cbfa1/Pebp2αA During Angiogenesis in Postnatal Rodent and Fetal Human Orofacial Tissues , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  G. Reddy.  AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. , 2004, Microvascular research.

[36]  A. Van der Laarse,et al.  Vascular smooth muscle cells and calcification in atherosclerosis. , 2004, American heart journal.

[37]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[38]  Yasmin,et al.  Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. , 2004, Arthritis and rheumatism.

[39]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[40]  P. Weissberg,et al.  Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[41]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[42]  R. Aebersold,et al.  Smooth Muscle Cell Phenotypic Transition Associated With Calcification: Upregulation of Cbfa1 and Downregulation of Smooth Muscle Lineage Markers , 2001, Circulation research.

[43]  M. Engelse,et al.  Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. , 2001, Cardiovascular research.

[44]  Sachiko Hattori,et al.  High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells , 2000 .

[45]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[46]  R. Natarajan,et al.  Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. , 1999, Diabetes.

[47]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[48]  E. Olson,et al.  Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells , 1996, The Journal of cell biology.

[49]  E. Morrisey,et al.  Structure and Expression of a Smooth Muscle Cell-specific Gene, SM22α (*) , 1995, The Journal of Biological Chemistry.

[50]  S. Glagov,et al.  Structural Basis for the Static Mechanical Properties of the Aortic Media , 1964, Circulation research.

[51]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[52]  K. Griendling,et al.  Serial Review : The Role of Oxidative Stress in Diabetes mellitus Serial Review , 2006 .

[53]  Thomas E Novotny,et al.  US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy. , 2006, American journal of public health.

[54]  F. Potier,et al.  What is known , 2003 .

[55]  J. Remacle,et al.  Development of a sensitive multi-well colorimetric assay for active NFkappaB. , 2001, Nucleic acids research.

[56]  S Hattori,et al.  High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. , 2000, Cardiovascular research.

[57]  E. Morrisey,et al.  Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. , 1995, The Journal of biological chemistry.

[58]  E. N. Smolar.  Diabetes and hypertension. , 1995, Comprehensive therapy.

[59]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[60]  G. Stein,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Differential Regulation of the Two Principal Runx2/Cbfa1 N-Terminal Isoforms in Response to Bone Morphogenetic Protein-2 during Development of the , 2022 .